The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial

NCT05101798 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped NX Development Corporation closed the trial

Conditions

Neoplasm
Skull Base Neoplasm

Interventions

DRUG: 5-Aminolevulinic acid Hydrochloride

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]